Declining prevalence of multidrug-resistant but comparatively high quinolone-resistant tuberculosis in Heilongjiang Province, China: 2013–2022 trend

Authors:

Abstract
The spread of multidrug-resistant tuberculosis (MDR-TB) remains a major problem globally. China is the high-burden country for TB, TB/HIV and MDR/rifampici
Funding Information
  • the Grant for Innovation Team Program of Heilongjiang Province
  • National Natural Science Foundation of China (82272345)

This publication has 11 references indexed in Scilit: